Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biopharma In 2013: A Rising Tide

Jan 23 2014

Related Content

Merck’s “Beyond The Pill” Bet, Vree Health, Goes Commercial

Oct 18 2013

Medication Adherence: A Positive Story You Are Not Hearing

Nov 20 2013

Roche Experimenting With New Pricing Models In Oncology

Jun 19 2013

Biopharma M&A In An Era Of Elusive Growth, Capital Triage, and New Competitors

Jun 19 2013

2013’s Top Biopharma Dealmakers

Jan 20 2014

Drug Spending Expected To Rise By $200 Bil. In 2022 Compared To Pre-ACA Levels

Sep 24 2013

Pharmacyclics/Janssen Offer Suite Of Patient Support Programs For <em>Imbruvica</em>

Nov 18 2013

Related Companies

Johnson & Johnson

GSK plc

Merck & Co., Inc.

Intercept Pharmaceuticals, Inc.

Roche Holding AG

Genentech, Inc.

Genentech, Inc.

Johnson & Johnson

Pharmacyclics, Inc.

Bausch Health Companies Inc.

Biogen, Inc.

Bristol Myers Squibb Company

Gilead Sciences, Inc.

Regeneron Pharmaceuticals, Inc.

Vertex Pharmaceuticals Incorporated

Express Scripts Holding Company

CVS Health Corp.

Novo Nordisk A/S

Pfizer Inc.

Zhejiang Hisun Pharmaceutical Co. Ltd.

Additional Topics

Business Strategies Deals Reimbursement Regulation BioPharmaceutical

More from Business Strategy

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window